These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 9374778
1. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Yamamoto K, Burnett JC, Redfield MM. Am J Physiol; 1997 Nov; 273(5):H2406-14. PubMed ID: 9374778 [Abstract] [Full Text] [Related]
2. Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs. Hart CY, Hahn EL, Meyer DM, Burnett JC, Redfield MM. Am J Physiol Heart Circ Physiol; 2001 Jul; 281(1):H146-54. PubMed ID: 11406479 [Abstract] [Full Text] [Related]
3. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors. Wada A, Tsutamoto T, Matsuda Y, Kinoshita M. Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118 [Abstract] [Full Text] [Related]
4. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y, Matsuoka H, Suzuki E, Hayakawa H, Sugimoto T, Matsuda Y, Morishita Y, Kangawa K, Minamino N, Matsuo H. Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [Abstract] [Full Text] [Related]
5. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. Matsumoto T, Wada A, Tsutamoto T, Omura T, Yokohama H, Ohnishi M, Nakae I, Takahashi M, Kinoshita M. Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673 [Abstract] [Full Text] [Related]
7. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T. Int J Cardiol; 2005 Oct 10; 104(3):332-7. PubMed ID: 16186065 [Abstract] [Full Text] [Related]
8. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure. Stevens TL, Rasmussen TE, Wei CM, Kinoshita M, Matsuda Y, Burnett JC. J Card Fail; 1996 Jun 10; 2(2):119-25. PubMed ID: 8798113 [Abstract] [Full Text] [Related]
9. C-type natriuretic peptide increases myocardial contractility and sinus rate mediated by guanylyl cyclase-linked natriuretic peptide receptors in isolated, blood-perfused dog heart preparations. Hirose M, Furukawa Y, Kurogouchi F, Nakajima K, Miyashita Y, Chiba S. J Pharmacol Exp Ther; 1998 Jul 10; 286(1):70-6. PubMed ID: 9655843 [Abstract] [Full Text] [Related]
10. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Rademaker MT, Charles CJ, Kosoglou T, Protter AA, Espiner EA, Nicholls MG, Richards AM. Am J Physiol; 1997 Nov 10; 273(5):H2372-9. PubMed ID: 9374774 [Abstract] [Full Text] [Related]
11. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. Ohte N, Cheng CP, Suzuki M, Little WC. J Pharmacol Exp Ther; 1999 Nov 10; 291(2):589-95. PubMed ID: 10525076 [Abstract] [Full Text] [Related]
12. Maximizing the natriuretic peptide system in experimental heart failure: subcutaneous brain natriuretic peptide and acute vasopeptidase inhibition. Chen HH, Lainchbury JG, Harty GJ, Burnett JC. Circulation; 2002 Feb 26; 105(8):999-1003. PubMed ID: 11864932 [Abstract] [Full Text] [Related]
13. Hemodynamic response to intracoronary infusion of atrial natriuretic factor in patients with normal or altered left ventricular function. Dubois-Rande JL, Adnot S, Benvenuti C, Merlet P, Hittinger L, Sediame S, Chabrier E, Braquet P, Castaigne A. J Cardiovasc Pharmacol; 1991 Apr 26; 17(4):608-14. PubMed ID: 1711628 [Abstract] [Full Text] [Related]
14. Effect of PDE5 inhibition on coronary hemodynamics in pacing-induced heart failure. Chen Y, Traverse JH, Hou M, Li Y, Du R, Bache RJ. Am J Physiol Heart Circ Physiol; 2003 May 26; 284(5):H1513-20. PubMed ID: 12679324 [Abstract] [Full Text] [Related]
15. Role for the endogenous natriuretic peptide system in the control of basal coronary vascular tone in dogs. Supaporn T, Wennberg PW, Wei CM, Kinoshita M, Matsuda Y, Burnett JC. Clin Sci (Lond); 1996 May 26; 90(5):357-62. PubMed ID: 8665772 [Abstract] [Full Text] [Related]
16. Renal effects of high-dose natriuretic peptide receptor blockade in rats with congestive heart failure. Zhang PL, Mackenzie HS, Totsune K, Troy JL, Brenner BM. Circ Res; 1995 Dec 26; 77(6):1240-5. PubMed ID: 7586237 [Abstract] [Full Text] [Related]
17. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure]. Kobusiak-Prokopowicz M, Swidnicka-Szuszkowska B, Mysiak A. Pol Arch Med Wewn; 2001 Jun 26; 105(6):475-82. PubMed ID: 11865578 [Abstract] [Full Text] [Related]
18. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, Jougasaki M, Kikuta K, Kato H, Tanaka H. J Am Coll Cardiol; 1995 Feb 26; 25(2):342-8. PubMed ID: 7829786 [Abstract] [Full Text] [Related]
19. Decreased regional lactate production and output due to intracoronary continuous infusion of esmolol during acute coronary occlusion in dogs. Sidi A, Rush W. J Cardiothorac Vasc Anesth; 1991 Jun 26; 5(3):237-42. PubMed ID: 1677824 [Abstract] [Full Text] [Related]
20. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, Imura H. Circulation; 1991 Oct 26; 84(4):1581-8. PubMed ID: 1914098 [Abstract] [Full Text] [Related] Page: [Next] [New Search]